Jul 30, 2026 07:00AM
May 12, 2026 06:30AM
Apr 30, 2026 07:00AM
Mar 31, 2026 06:30AM
Mar 3, 2026 07:30AM
Feb 24, 2026 07:30AM
Feb 24, 2026 07:30AM Keenova Unveils Clinical Data from Phase 2 Plantar Fibromatosis Study at the ACFAS Annual Meeting
Feb 16, 2026 07:30AM
Jan 21, 2026 07:30AM
Jan 13, 2026 04:47PM
Jan 13, 2026 04:45PM
Nov 10, 2025 07:00AM
Nov 10, 2025 06:30AM
Nov 10, 2025 06:30AM Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics
Oct 23, 2025 08:00AM
Aug 6, 2025 06:30AM
Aug 1, 2025 07:00AM
Aug 1, 2025 07:00AM
Jul 22, 2025 06:45AM
Jun 9, 2025 08:33AM
Jun 9, 2025 08:30AM Mallinckrodt, Endo Announce Planned Leadership Team for Merged Company
May 13, 2025 08:00AM
May 6, 2025 06:45AM
Apr 10, 2025 06:45AM
Mar 13, 2025 06:31AM
Mar 13, 2025 06:31AM
Mar 13, 2025 06:30AM
Mar 10, 2025 04:30PM Mallinckrodt plc Reschedules Release of Fourth Quarter and Fiscal Year 2024 Financial Results to Thursday, March 13, 2025
Feb 27, 2025 01:00PM
Dec 2, 2024 06:45AM
Nov 5, 2024 06:45AM
Oct 24, 2024 06:45AM
Aug 6, 2024 06:45AM
Aug 5, 2024 07:00AM
Aug 5, 2024 07:00AM Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million
Aug 1, 2024 08:59AM
May 9, 2024 06:45AM
Mar 26, 2024 04:01PM
Mar 11, 2024 11:34AM
Aug 30, 2023 11:54AM
Aug 28, 2023 05:02AM
Aug 28, 2023 12:17AM Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations
Aug 23, 2023 08:22AM
Aug 9, 2023 06:48AM
Aug 9, 2023 06:45AM
May 9, 2023 06:47AM
May 9, 2023 06:45AM
Apr 24, 2023 06:45AM
Feb 28, 2023 06:45AM Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance
Feb 8, 2023 06:45AM

1,216,120 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All